In May, the FDA approved another biomarker to help millions of patients and families affected by Alzheimer’s disease: a blood test that detects amyloid plaques, a hallmark of the disease.

WPXI-TV spoke with those fighting for a cure here in the Pittsburgh area. Sara Murphy, vice president for programs and services for the Greater Pennsylvania chapter of the Alzheimer’s Association, said while there’s still work to be done, this FDA clearance is a huge step for early detection.